Literature DB >> 17086063

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.

Vincent Soriano, Pablo Labarga, Andrés Ruiz-Sancho, Javier Garcia-Samaniego, Pablo Barreiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17086063     DOI： 10.1097/01.aids.0000247583.38943.95

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  12 in total

1.  Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.

Authors:  Valentina Li Vecchi; Maurizio Soresi; Claudia Colomba; Giovanni Mazzola; Pietro Colletti; Maurizio Mineo; Paola Di Carlo; Emanuele La Spada; Giovanni Vizzini; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Triplex forming oligonucleotides against type α1(I) collagen attenuates liver fibrosis induced by bile duct ligation.

Authors:  Ravikiran Panakanti; Akshay Pratap; Ningning Yang; John S Jackson; Ram I Mahato
Journal:  Biochem Pharmacol       Date:  2010-09-09       Impact factor: 5.858

3.  Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride-induced liver fibrosis in rats.

Authors:  Nermeen N El-Agroudy; Reem N El-Naga; Rania Abd El-Razeq; Ebtehal El-Demerdash
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

Review 4.  Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review.

Authors:  Ashwani-K Singal; Bhupinderjit S Anand
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

Review 5.  HCV and HIV co-infection: mechanisms and management.

Authors:  Jennifer Y Chen; Eoin R Feeney; Raymond T Chung
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-02-18       Impact factor: 46.802

Review 6.  Update on HIV/HCV coinfection.

Authors:  Vincent Soriano; Eugenia Vispo; Jose Vicente Fernandez-Montero; Pablo Labarga; Pablo Barreiro
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.495

7.  Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study.

Authors:  Kali Zhou; Fengyu Hu; Charles Wang; Min Xu; Yun Lan; Jamie P Morano; Stanley M Lemon; Joseph D Tucker; Weiping Cai
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

8.  Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.

Authors:  Xin Shen; Sisi Cheng; Yu Peng; Hongli Song; Hanmin Li
Journal:  BMC Complement Altern Med       Date:  2014-10-27       Impact factor: 3.659

Review 9.  Hepatitis C virus infection: looking for interferon free regimens.

Authors:  J González-Moreno; A Payeras-Cifre
Journal:  ScientificWorldJournal       Date:  2013-04-09

10.  Meta-analysis of the clinical value of danshen injection and huangqi injection in liver cirrhosis.

Authors:  Changtai Zhu; Hao Cao; Xifa Zhou; Chunlei Dong; Judong Luo; Changsong Zhang; Jinming Liu; Yang Ling
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-28       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.